Article

IKA Keratoconus Symposium 2023: New data presented for epi-on cross-linking

John D. Gelles, OD, and Steven A. Greenstein, MD, share some insights into the new data on corneal cross-linking presented at IKA Keratoconus Symposium.

Video transcript

John D. Gelles, OD, FAAO, FIAOMIC, FCLSA, FSLS:
I'm John Gelles from the Cornea & Laser Eye Institute, the CLEI Center for Keratoconus.

Steven A. Greenstein, MD:
And I'm Steven Greenstein from the Cornea & Laser Eye Institute as well and the CLEI Center for Keratoconus. We're really excited to be at the first annual IKA meeting; we've heard so many amazing presentations.

We spoke about some of the new and exciting data on cross-linking, particularly epi-on cross-linking and some of the adjunctive treatments like topo-guided PRK and corneal inlays with cross-linking treatment.

Gelles:
Yes, this this lecture was really seminal in this because we're trying to accomplish the concept of comprehensive keratoconus management and going from not just stability, but also what you can do to improve corneal topography and to improve vision for individuals so that you're taking into account not just their vision with contact lenses, but also their vision when they're not wearing their contacts.

Greenstein:
We look forward to the next meeting next year in Washington, DC!

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.